Session Details
[P]Herpesvirales
Mon. Nov 2, 2026 11:00 AM - 5:05 PM JST
Mon. Nov 2, 2026 2:00 AM - 8:05 AM UTC
Mon. Nov 2, 2026 2:00 AM - 8:05 AM UTC
Poster : Herpesvirales (2F Convention Hall AB)
[P-4]Single-Cell Transcriptomics with SingleViral Uncovers Lytic HHV-6 Infection and Reactivation in CAR-T Cells
*Huamin Tang1, Yu Zhang1, Emanuela Garbarino2, Gradimir Misevic2, Jingjing Ma3, Junli Jia1 (1. Nanjing Medical University, China, 2. Institute of Colloid and Biointerface Science - Boku University - Vienna - AT, 3. Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, China.)
[P-5]Live-cell imaging analysis of RNA polymerase II phosphorylation during Epstein–Barr virus lytic infection
*Hiroshi Kitamura1, Keiju Kamijo1, Michi Miura1, Hiroshi Kitamura2, Teru Kanda1 (1. Tohoku Medical and Pharmaceutical University, 2. Institute of Science Tokyo)
[P-6]Latent infection mechanism of human cytomegalovirus in glial cells
*Kazuya Shimada1, Naomi Oka1, Azusa Ishii1, Yohei Watanabe1, Kazuhiro Kondo1 (1. The Jikei University)
[P-7]Functional Analysis of the ORF67 and ORF69 Genes of Kaposi's Sarcoma-Associated Herpesvirus (KSHV)
*Takara Ikeda1, Yuki Iwaisako1, Asuka Tatibana1, Yuka Nakamori1, Masahiro Fujimuro1 (1. Kyoto Pharmaceutical University)
[P-8]HSV-1-infected cells produce amyloid beta aggregates with neurotoxic activity.
*Kanemaki Sana1, Suga Kei2, Nakaso Kazuhiro3, Fujimuro Masahiro1 (1. Cell Biol., Kyoto Pharm. Univ., 2. Chem., Faculty of Medicine, Kyorin Univ., 3. Biochem., Faculty of Medicine, Tottori Univ.)
[P-9]Analyses of the progression of Epstein-Barr virus DNA replication using a highly sensitive FISH protocol and the development of a machine learning model
*Teru Kanda1, Hiroshi Kitamura1, Michi Miura1, Keiju Kamijo1, Akihiro Kurimasa1 (1. Tohoku Medical and Pharmaceutical University)
[P-10]The Effect of the Placental Environment on Cytomegalovirus Proliferation
*Tomoya Shigoku1, Ayaka Kudo1, Hiroshi Sakurai1, Kazufumi Ikuta1 (1. Kanazawa University)
[P-11]Systematic Screening of BHV-1 Permissiveness in a Multi-Species Cell Panel
*Warisa Ketphan1,2, Tatsuya Usui2,3, Hiroshi Shimoda4, Tetsuya Mizutani1,2, Hitoshi Takemae1,2 (1. Center for Infectious Disease Epidemiology and Prevention Research, Tokyo Univ. of Agriculture and Technology, 2. Cooperative division of Vet. Science, Tokyo Univ. of Agriculture and Technology, 3. Laboratory of Vet. Pharmacology, Department of Vet. Med., Faculty of Agriculture, Tokyo Univ. of Agriculture and Technology, 4. Laboratory of Vet. Microbiol., Joint Graduate School of Vet. Med., Yamaguchi Univ.)
[P-12]Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
*Satoru Kondo1 (1. Kanazawa university)
[P-13]EBV LMP-1 Promotes B Cell Lymphoma Through AP-1-Dependent Induction of AICDA.
*Shaheen Mowla Mowla1, Lungile Mapekula1, Dharshnee Chetty1 (1. University of Cape Town)
[P-14]Isolation and characterization of gammaherpesviruses derived from greater horseshoe bats in Kagoshima Prefecture, Japan
*Moko Hidaka1, Mana Esaki2, Isshu Kojima3, Kimitake Funakoshi4, Masahiro Kajihara5, Shin Murakami6, Makoto Ozawa1,2, Kosuke Okuya1 (1. Joint Faculty of Veterinary Medicine, Kagoshima University, 2. Joint Graduate School of Veterinary Medicine, Kagoshima University, 3. Faculty of Veterinary Medicine, Okayama University of Science, 4. Faculty of Intercultural Studies, The International University of Kagoshima, 5. International Institute for Zoonosis Control, Hokkaido University, 6. Graduate School of Agricultural and Life Sciences, The University of Tokyo)
[P-15]Development of monoclonal antibodies against herpes B virus envelope proteins and their application for detecting herpes B virus-specific antibodies
*Hitomi Kinoshita1, Madoka Kawahara1, Tomoki Yoshikawa1, Phu Hoang Anh Nguyen1, Souichi Yamada1, Shizuko Harada1, Hideki Ebihara1, Shuetsu Fukushi1 (1. National Institute of Infectious Diseases)
[P-16]Differences in immune responses between primary and reactivation of human betaherpesvirus 6B: single-cell RNA sequencing and serum biomarker analysis
*Yoshiki Kawamura1,2, Yoshitaka Sato3, Yusuke Tsumura4, Manabu Wakamatsu4, Shiori Endo3, Takako Suzuki4, Yuki Higashimoto5, Hiroki Miura1, Yotaro Kondo1, Masaru Ihira6, Yusuke Okuno7, Hiroshi Kimura3, Tetsushi Yoshikawa1, Jun-ichi Kawada1 (1. Department of Pediatrics, Fujita Health University School of Medicine, 2. Department of Pediatrics, Fujita Health University Okazaki Medical Center, 3. Nagoya University Graduate School of Medicine, 4. Department of Pediatrics, Nagoya University Hospital, 5. Department of Clinical Microbiology, Fujita Health University School of Medical Sciences, 6. Department of Clinical Science for Biological Monitoring, Fujita Health University School of Medical Sciences, 7. Department of Virology, Nagoya City University Graduate School of Medical Sciences)
[P-17]Identification and Characterization of a Viral Fc-gamma Receptor in Guinea Pig Cytomegalovirus
Hiroki Kondo1, Kazuhisa Tsukuda1, Yukiya Okada1, Kurumi Nakamura1, Juri Koizumi1, Keita Takahashi1, *Tetsuo Koshizuka1 (1. Microbiology and Immunology, Gifu Pharmaceutical University)
[P-18]IgG3-skewed Response Underestimates Pediatric Varicella Vaccine Immunity Measured by Commercial gpELISA Without Compromising Fc-Mediated Functions
*Ji-young Hwang1,2, Kyung-min Lee1,2, Yunhwa kim1,2, Sivilay Xayaheuang1, Ji Yun Noh3, Keun-Mi Lee4, Hosun Park1,2 (1. Department of Microbiology, College of Medicine, Yeungnam University, Daegu, Republic of Korea, 2. Immunogenicity Evaluation Laboratory, Clinical Trial Center, Yeungnam University Medical Center, Daegu, Republic of Korea, 3. Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea, 4. Department of Family Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea)
[P-19]Development of Neutralizing Antibodies Against Human Cytomegalovirus pentamer and gB
*Satoko Iwahori1, Nobuko Ohshima1, Gene Kurosawa2, Kazuhiro Morishita3, Toshio Minematsu4, Masatoki Kaneko3, Takayuki Murata1 (1. Fujita Health University, 2. Nagoya University, 3. University of Miyazaki, 4. Aisenkai Nichinan Hospital)
[P-20]Role of UL50 Mutation in Ganciclovir Resistance in recombinant HSV-1
*PhuHoangAnh NGUYEN1, Souichi Yamada1, Fujii Hikaru2, Hitomi Kinoshita1, Harada Shizuko1, Hideki Ebihara1, Masayuki Saijo1,3, Shuetsu Fukushi1 (1. Department of Virology 1, National Institute of Infectious Diseases, Japanese Institute for Health Security, Tokyo 162-8640, Japan, 2. The Faculty of Veterinary Medicine, Okayama University of Science, Imabari, 794-8555, Ehime, Japan, 3. Municipal Hakodate Health center, Hakodate 040-0001, Hokkaido, Japan)
[P-21]Enhanced antitumor effect of oncolytic virus G47delta by Juzen-taiho-to
*Shinichi Esaki Esaki1, Fumi Goshima1, Arima Sachie1, Daikoku Toru2, Shinichi Iwasaki1 (1. Nagoya City University Graduate School of Medical Sciences and Medical School, 2. Hokuriku University)
[P-22]Establishment of an alternative method for herpesvirus latent infection models
*Seiichi Tanaka1 (1. Center for Experimental Animals, Fukuoka University)
[P-23]Growth kinetics of feline herpesvirus 1 in non-host-derived cells
*Hikaru Fujii1, Junki Kikuta1, Aoi Kikuiri1, Shumpei Watanabe1 (1. Okayama University of Science)
[P-24]Development of an Epstein–Barr Virus–Specific Cellular Immunity Assay
*Ayaka Kudo1, Tomoya Shigoku1, Satomi Nagaya1, Takamasa Katagiri1, Kazufumi Ikuta1 (1. Kanazawa University)
